Skip to main content

Month: March 2022

Patriot Battery Metals Announces Mobilization of First Drill Rig to the Corvette Lithium Property, James Bay, Quebec

VANCOUVER, British Columbia, March 01, 2022 (GLOBE NEWSWIRE) — Patriot Battery Metals Inc. (the “Company” or “Patriot”) (CSE: PMET) (OTCQB: PMETF) (FSE: R9GA) is pleased to announce it has mobilized the first of two drill rigs to commence the winter drill program at its wholly owned Corvette Lithium Property (the “Property”), located in the James Bay Region of Quebec. The target drill area at the CV Lithium Trend is located approximately 13.5 km south of the regional and all-weather Trans-Taiga Road and powerline infrastructure. The winter phase of the planned 15,000 to 20,000 m drill exploration campaign will focus on further delineation of the CV1 through CV7 lithium pegmatite outcrop corridor, where the initial four (4) drill holes to test the CV5-6 Prospect returned strong lithium-tantalum mineralization. This is highlighted...

Continue reading

Gain Therapeutics Announces Participation in Upcoming Investor and Scientific Conferences

– Oppenheimer 32nd Annual Healthcare Conference – – AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders – – Krabbe Translational Research Network Meeting – BETHESDA, Md., March 01, 2022 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a biotechnology company focused on identifying and optimizing allosteric binding sites that have never been targeted in neurodegenerative diseases and lysosomal storage disorders, today announced that it will be participating in upcoming investor and scientific conferences. Eric Richman, Chief Executive Officer of Gain Therapeutics, will present at the Oppenheimer 32nd Annual Healthcare Conference and invites investors to participate via webcast and in one-on-one meetings. The company...

Continue reading

Caladrius Biosciences Receives $2.3 Million of Non-Dilutive Capital Through New Jersey Technology Business Tax Certificate Transfer Program

BASKING RIDGE, N.J., March 01, 2022 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of innovative therapies designed to treat or reverse disease, today announced that it has received $2.3 million in non-dilutive funding as an approved participant of the Technology Business Tax Certificate Transfer Program (the “Program”) sponsored by the New Jersey Economic Development Authority (“NJEDA”). The Program enables qualifying New Jersey-based biotechnology or technology companies to sell a percentage of their New Jersey net operating losses (“NOLs”) and research and development tax credits to unrelated qualifying corporations. “We appreciate the NJEDA’s continued support of the New Jersey biotech community under this...

Continue reading

SomaLogic to Announce Fourth Quarter and Full Year 2021 Financial Results

BOULDER, Colo., March 01, 2022 (GLOBE NEWSWIRE) — SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that it will report financial results for the fourth quarter and full year 2021 after market close on Tuesday, March 29, 2022. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing (844) 535-4027 for domestic callers or (270) 215-9487 for international callers, using conference ID: 2758178. A live audio webcast and an archive of the presentation will be available through the Investors page of SomaLogic’s corporate website at https://investors.somalogic.com. About SomaLogicSomaLogic (Nasdaq: SLGC) seeks to deliver precise, meaningful, and actionable health-management information...

Continue reading

Crinetics Pharmaceuticals Expands Executive Team with Appointment of James Hassard as Chief Commercial Officer

SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced the appointment of James Hassard as chief commercial officer. Mr. Hassard is a commercial leader with more than three decades of experience leading sales and marketing operations for both global and domestic biotechnology companies. Scott Struthers, Ph.D., founder and chief executive officer of Crinetics, stated, “In addition to his deep biopharmaceutical experience, Jim’s background as a pharmacologist gives him valuable scientific insight that informs his commercial strategy. These are critical skills that we will leverage across our pipeline...

Continue reading

SafeVchat™ Sees Demand Surge from Healthcare Providers for Secure Video Conferencing Solutions as Russian Threat Intensifies

EDISON, N.J., March 01, 2022 (GLOBE NEWSWIRE) — StrikeForce Technologies, Inc. (OTCQB: SFOR), a Cyber Security company that provides next-gen secure video conferencing, today announced that on the heels of the Russian invasion of Ukraine it has seen a surge of interest for its SafeVchat secure video conferencing & collaboration platform, especially within the healthcare industry. Cyber Security is more critical than ever given the global unrest fueled by Russian aggression. SafeVchat meets the needs of security-minded users who now have more concerns than ever over privacy, data accessibility, and the threat of hacks and cyber-attacks. “We see attacks like the recent Microsoft video conferencing breaches as underscoring a need more than ever to tighten up on clear areas of vulnerability, like privacy-weak video conferencing...

Continue reading

GBT Developing a Proprietary Cryptographic Technology – Designed to Secure a Long-Range Radio Communication System

SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT” or the “Company”), is developing a proprietary cryptographic technology to secure its long range radio system, which has been assigned an internal project code name of Infinia. The Infinia System design contemplates communication through ionospheric propagation environment with the goal of reaching long distances, creating a private, secured radio frequency (RF) network. The main aim of the application-specific, cybersecurity technology is to create secured level communications with the goal of serving military and governmental applications. The Infinia System is being developed with the goal of using a few types of encryptions/decryptions techniques, including authentication/authorization measures to ensure robust wireless network...

Continue reading

Clean Earth Mobile Services Obtains Exclusive On-Site Soil and Sediment Treatment Permit in Connecticut

The specialty waste processing Company obtains the only on-site hazardous soil and sediment waste treatment permit in ConnecticutWith a focus on sustainability, Clean Earth further legitimizes its mobile soil and sediment treatment services as an environmental solution provider to customers at their sitesKING OF PRUSSIA, Pa., March 01, 2022 (GLOBE NEWSWIRE) — Clean Earth, a division of Harsco Corporation and a leading provider in environmental and regulated waste management services, announced that its Clean Earth Mobile Services Solutions business is now uniquely equipped to provide on-site treatment services to the Connecticut market. With this permit, the Company offers the only on-site hazardous soil and sediment treatment solution in the state. The permit allows Clean Earth to treat hazardous soil and sediment on-site...

Continue reading

Monticello Joins an International Group to Strengthen Its Offering

Agreement reached between Monticello and BIP, a consulting multinational in Italy NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) — Monticello Consulting Group, a leader in the financial services sector and one of the best recognized consulting firms in the Capital Markets segment, announces an agreement reached with BIP, a multinational consulting company. The two consulting firms have signed an agreement for the acquisition by BIP of Monticello’s equity, in which the current ownership will continue to hold a significant stake in the Company. In addition, CEO Will Morgan will continue to lead the operations in the United States. Founded in Italy in 2003, with global revenue of 347 million euros as of 30 September 2021, BIP now has over 4,000 professionals in the main European, American and Middle Eastern countries. This transaction...

Continue reading

Sentry Management Expands HOA Management Services to Southeast Michigan

Sentry Management Expands HOA Management Services to Southeast Michigan From left to right: Kregg Hale, SVP, Acquisitions & Training at Sentry Management; Bradley Pomp, President, Sentry Management; Glynis McBain, YPM Owner and new Market President for Sentry Management Southeast Michigan; and Brian McBain, YPM OwnerHowell, MI, March 01, 2022 (GLOBE NEWSWIRE) — Sentry Management, Inc., a national leader in homeowner association and condominium management, has announced a partnership with community and condo management company Your Peace of Mind (YPM), located in Howell, MI. With this new partnership, Sentry Management now operates more than 40 offices across 20 states. YPM has been a leader in community association management in the Southeast Michigan area for more than 20 years, focusing on residential and commercial condominium...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.